Sam Mount, E’17, will begin a co-op next month with Dimension Therapeutics, a company dedicated to advancing novel treatments for patients living with severe, genetic disorders associated with the liver. Here, he talks about how co-op and research opportunities broaden the academic experience. Share your story by using #TrueNortheastern on social media.